Abstract
Telocytes (TCs) were previously shown by our group to form a tandem with stem/progenitor cells in cardiac stem cell (CSC) niches, fulfilling various roles in cardiac renewal. Among these, the ability to ‘nurse’ CSCs in situ, both through direct physical contact (junctions) as well as at a distance, by paracrine signalling or through extracellular vesicles containing mRNA. We employed electron microscopy to identify junctions (such as gap or adherens junctions) in a co‐culture of cardiac TCs and CSCs. Gap junctions were observed between TCs, which formed networks, however, not between TCs and CSCs. Instead, we show that TCs and CSCs interact in culture forming heterocellular adherens junctions, as well as non‐classical junctions such as puncta adherentia and stromal synapses. The stromal synapse formed between TCs and CSCs (both stromal cells) was frequently associated with the presence of electron‐dense nanostructures (on average about 15 nm in length) connecting the two opposing membranes. The average width of the synaptic cleft was 30 nm, whereas the average length of the intercellular contact was 5 μm. Recent studies have shown that stem cells fail to adequately engraft and survive in the hostile environment of the injured myocardium, possibly as a result of the absence of the pro‐regenerative components of the secretome (paracrine factors) and/or of neighbouring support cells. Herein, we emphasize the similarities between the junctions described in co‐culture and the junctions identified between TCs and CSCs in situ. Reproducing a CSC niche in culture may represent a viable alternative to mono‐cellular therapies.
Keywords: cardiac telocytes, telopodes, cardiac stem cells, gap junctions, adherens junctions, stromal synapse
Introduction
Regenerative medicine and specifically stem cell therapies show the greatest promise in correcting the extensive ventricular scarring and massive cell loss following ischaemic events in coronary heart disease. Different cell types have been investigated and even considered for regeneration of the injured heart in animal models and humans, of which notably: embryonic stem cells(ESCs), adipose‐derived stem cells, mesenchymal stem cells, bone marrow‐derived cells and CSCs 1, 2, 3, 4, 5, 6, 7, 8, 9. Unfortunately, the results have been unconvincing and sometimes contradictory, due mainly to less than ideal cell delivery methods and poor cell engraftment and survival 10, 11, 12, 13, 14, 15, 16, 17, 18. The very low survival rate is suggested to be caused by the notoriously ‘hostile environment’ of the infarcted region, characterized by ischaemia, a heightened inflammatory response, lingering pro‐apoptotic signals and by the absence of an extracellular matrix 19, 20. In addition, successful stem cell engraftment appears to be dependent on the presence of various paracrine factors (e.g. growth factors, cytokines, chemokines) and extracellular vesicles, part of the so called ‘secretome’ released by stem cells and/or other neighbouring cells within CSC niches 14, 21, 22, 23, 24. It, therefore, becomes obvious that understanding the signalling mechanisms between support and stem cells, or even replicating the architecture of CSC niches in vitro prior to transplantation, is key for improving current therapies 25.
Among the cell types recently suggested to be involved in cardiac homoeostasis and regeneration are TCs 26, 27, 28, 29. Telocytes are distinct interstitial cells found in most organs, characterized by the presence of lengthy extensions – telopodes (Tp) 30, 31, 32, 33, 34. Indeed, our group has shown that TCs form a complex network within the myocardium, communicating with adjacent cells both through direct physical contact as well as by means of paracrine signalling 35, 36. Cardiac TCs shed at least three different types of extracellular vesicles in situ 36, 37 and in culture 38. In an experiment involving Cy5‐labelled oligoRNAs, these vesicles were successfully transferred to stem cells in culture, indicating a potential similar mechanism for the transfer of regenerative factors 39. It is plausible that stem/progenitors cells are ‘nursed’ by TCs in CSC niches, thereby sustaining a continuous cardiac renewal process in the adult mammalian heart 35, 36, 40, 41.
In this work, we demonstrate that TCs form ‘atypical’ junctions with stem cells not only in tissue but also in culture.
Materials and methods
Cell culture
Cardiac TCs were isolated from the hearts of 3‐month‐old Wistar rats and cultured as described previously 34, 39. Laboratory animals were handled in accordance with the ‘Victor Babeș’ Institute Ethics Board guidelines. Rat CSCs were a kind gift from Prof. Piero Anversa (Brigham and Women Hospital, Boston, MA, USA). This cell line is described elsewhere 42, 43.
Transmission electron microscopy
Cells cultured for 24 and 48 hrs, were fixed and embedded in epoxy resin (Agar 100) as described previously 38. Ultra‐thin sections (~60 nm) were then obtained using a diamond knife, double stained with 1% uranyl acetate and Reynolds lead citrate and finally visualized using a Morgagni 268 TEM (FEI Company, Eindhoven, The Netherlands) at 80 kV. Digital electron micrographs were recorded using a MegaView III CCD. Image processing was done using iTEM‐SIS software (Olympus, Munster, Germany). Samples originating from tissue 41 were used for comparison.
Results
Telocytes were identified in culture (Fig. 1) based on the presence of very long extensions (Tp), with lengths varying from 100 to 200 μm 38. Telopodes were frequently observed in apparent contact with either CSCs or other TCs (Fig. 1). Heterocellular contacts markedly increased in number after 48 hrs of culture and this corresponded to an increase in the number of CSCs (Fig. 1B) in the presence of TCs.
Telopodes originating from different TCs frequently formed homocellular networks, establishing both adherens (AJ) and gap junctions (GJ) at the site of contact (Fig. 2) and this was consistent with previous observations of TCs in tissue 36. Gap junctions were easily observed connecting cultured TCs to other TCs (Fig. 2C), however, not TCs to CSC. Interestingly, no GJs could be identified between TCs in the cardiac tissue.
Telocytes formed junctions with adjacent CSCs (Figs 3, 4, 5A), identified as stromal synapses (Figs 3 and 4). The length of TC–CSC stromal synapse ranged from 1.8 to 12.9 μm, with a global average of 5.5 ± 5.1 μm at 24 hrs of culture (mean ± S.D.). The intercellular distance between TC–CSC at the interface (synaptic cleft) varied between 9.9 and 58.8 nm, with an average of 30.6 ± 12.8 nm (mean ± S.D.). Numerous electron‐dense nanostructures could be observed in the synaptic cleft between TCs and CSCs (Figs 4B–D and 5A). These structures had a minimum length of 7.9 nm and a maximum length of 24 nm, with an average of 14.8 ± 4.5 nm (mean ± S.D.).
The Puncta adhaerentia type junction was infrequently found connecting TCs and CSCs (Fig. 4C). Telocytes and CSCs also maintained contact by means of paracrine signalling, via different types of extracellular vesicles (Fig. 5A), however, these are described elsewhere 38.
Intercellular contacts between TCs and CSCs were also analysed in tissue samples for comparison. The stromal synapse associated with electron‐dense nanostructures (Figs 5B and 6) was the most common type of junction found in tissue. The intercellular distances in tissue were between 20 and 30 nm and the minimum distance between the cellular membranes was approximately 15 nm. Contours drawn over the opposing cellular membranes emphasize the similarities of heterocellular junctions between the TCs and CSCs in culture and in tissue (Fig. 7).
Discussion
Here, we confirm that TCs display a similar morphology in culture as they do in tissue and form the same types of cell‐to‐cell junctions between themselves, as well as with CSCs, supporting the idea of an active involvement in the homoeostasis of cardiac tissue. This study suggests that replicating the architecture of CSC niches in vitro may be possible.
In tissue, TCs may be identified as a result of their peculiar morphology, with Tp forming vast cellular networks, and these characteristics were exhaustively discussed in a previous review from our group 31. In cardiac tissue especially, TCs were suggested to function as ‘nurse‐cells’ facilitating the maturation of cardiac stem/progenitor cells 35, 36, 40. However, although recent cell‐culture data indicated that TCs communicate over long distances with stem cells through extracellular vesicles 39, the direct contacts between TCs and other cell types in culture remained largely unexplored. Understanding cardiac heterocellular communication (Fig. 8), both direct 36 and through paracrine signalling 38, 39 may prove essential for successful cell‐based therapies.
Telocytes formed homocellular networks by means of GJs, however, no such junctions could be seen between TCs and CSCs in culture. This may have been the result of the relatively short culture times, but more likely represents a characteristic of the partnership between the two types of cells. Similarly, embryonic fibroblast feeder cells were not found to form GJs with human ESCs and mouse ESCs 44. In fact, heterocellular GJs are not normally seen between different cell types. Contrary to a previous report indicating that fibroblasts establish GJs with cardiomyocytes in tissue and in culture 45, our group has not been able to visualize such junctions between TCs and cardiomyocytes in tissue 36, reinforcing the idea that GJs are restricted to homocellular communication.
Telocytes formed both homocellular, as well as heterocellular AJs with CSCs. Classic AJs formed between stem and support cells in epithelial and stromal niches were previously shown to control the geometry of division, by facilitating the proper positioning of centrosomes 46. As we have seen an increase in the number of CSCs in the presence (but not the absence) of cardiac TCs, it could be speculated that similar mechanisms take place in CSC‐TC co‐cultures, however, this hypothesis warrants further study. Puncta adhaerentia, consisting of cadherin–catenin clusters, are found at cell–cell contacts often during early stages of AJ assembly 47 and such junctions were also seen in the case of TC–CSC cultures.
Additionally, previous studies from our group 36, 48 showed that heterocellular contacts in tissue can occur by means of stromal synapses and these were also observed in TC–CSC co‐cultures. Stromal synaptic regions, akin to immune synapses 49, 50, are defined by intercellular distances within the molecular interaction range (15–100 nm), allowing the presence of a gap (synaptic cleft) in which receptor–ligand interactions occur. Consistent with the observations of TCs and CSCs or cardiomyocytes in tissue 36, 48, 51, electron‐dense nanostructures connecting the two apposing membranes over distances shorter than 25 nm were frequently associated with these types of junctions. The molecular composition of these nanostructures is unknown.
The exact role of TCs in cardiac tissue regeneration remains an elusive, but desirable target, with potential applications in stem cell therapy. Future in‐depth studies of the molecular components of stromal synapse and the dynamics of these components in normal and diseased tissues will shed a new light on the signalling mechanisms between stem and support cells (Fig. 8). This, in turn, may help overcome the current limitations of stem cell engraftment in myocardial tissue following ischaemic events.
Conflicts of interest
The authors confirm that there are no conflicts of interest.
Acknowledgements
This work was supported by a grant of the Romanian National Authority for Scientific Research, CNCS – UEFISCDI, project number “350/2012 PN‐II‐ID‐PCE‐2011‐3‐0134” [MG, LMP] and partly supported by the Sectorial Operational Programme for Human Resources Development (SOPHRD), financed by the European Social Fund and the Romanian Government under contract number POSDRU 141531 (ETF).
References
- 1. Wollert KC, Drexler H. Cell therapy for the treatment of coronary heart disease: a critical appraisal. Nat Rev Cardiol. 2010; 7: 204–15. [DOI] [PubMed] [Google Scholar]
- 2. Malliaras K, Marbán E. Cardiac cell therapy: where we've been, where we are, and where we should be headed. Br Med Bull. 2011; 98: 161–85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Mingliang R, Bo Z, Zhengguo W. Stem cells for cardiac repair: status, mechanisms, and new strategies. Stem Cells Int. 2011; 2011: 310928. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Gherghiceanu M, Barad L, Novak A, et al Cardiomyocytes derived from human embryonic and induced pluripotent stem cells: comparative ultrastructure. J Cell Mol Med. 2011; 15: 2539–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Ellison GM, Vicinanza C, Smith AJ, et al Adult c‐kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell. 2013; 154: 827–42. [DOI] [PubMed] [Google Scholar]
- 6. Madonna R, Ferdinandy P, De Caterina R, et al Recent developments in cardiovascular stem cells. Circ Res. 2014; 115: e71–8. [DOI] [PubMed] [Google Scholar]
- 7. Gaetani R, Feyen DA, Doevendans PA, et al Different types of cultured human adult cardiac progenitor cells have a high degree of transcriptome similarity. J Cell Mol Med. 2014; 18: 2147–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Karantalis V, Hare JM. Use of mesenchymal stem cells for therapy of cardiac disease. Circ Res. 2015; 116: 1413–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Kim J, Shapiro L, Flynn A. The clinical application of mesenchymal stem cells and cardiac stem cells as a therapy for cardiovascular disease. Pharmacol Ther. 2015; 151: 8–15. [DOI] [PubMed] [Google Scholar]
- 10. Sheng CC, Zhou L, Hao J. Current stem cell delivery methods for myocardial repair. Biomed Res Int. 2013; 2013: 547902. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Gama‐Carvalho M, Andrade J, Brás‐Rosário L. Regulation of cardiac cell fate by microRNAs: implications for heart regeneration. Cells. 2014; 3: 996–1026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. van der Wall EE. Stem cell therapy for heart disease: truly beneficial? Neth Heart J. 2014; 22: 313–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Nowbar AN, Mielewczik M, Karavassilis M, et al Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta‐analysis. BMJ. 2014; 348: g2688. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Rosen MR, Myerburg RJ, Francis DP, et al Translating stem cell research to cardiac disease therapies: pitfalls and prospects for improvement. J Am Coll Cardiol. 2014; 64: 922–37. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Dorn GW 2nd. Cardiac regeneration ‐ Alchemy, science, and a wee bit of magic? J Mol Cell Cardiol. 2015; 81: 10–1. [DOI] [PubMed] [Google Scholar]
- 16. Gerbin KA, Murry CE. The winding road to regenerating the human heart. Cardiovasc Pathol. 2015; 24: 133–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Keith MC, Bolli R. “String theory” of c‐kit(pos) cardiac cells: a new paradigm regarding the nature of these cells that may reconcile apparently discrepant results. Circ Res. 2015; 116: 1216–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Alrefai MT, Murali D, Paul A, et al Cardiac tissue engineering and regeneration using cell‐based therapy. Stem Cells Cloning. 2015; 8: 81–101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Manole CG, Cismaşiu V, Gherghiceanu M, et al Experimental acute myocardial infarction: telocytes involvement in neo‐angiogenesis. J Cell Mol Med. 2011; 15: 2284–96. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Robey TE, Saiget MK, Reinecke H, et al Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol. 2008; 45: 567–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Anthony DF, Shiels PG. Exploiting paracrine mechanisms of tissue regeneration to repair damaged organs. Transplant Res. 2013; 2: 10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Barile L, Lionetti V, Cervio E, et al Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovasc Res. 2014; 103: 530–41. [DOI] [PubMed] [Google Scholar]
- 23. Albulescu R, Tanase C, Codrici E, et al The secretome of myocardial telocytes modulates the activity of cardiac stem cells. J Cell Mol Med. 2015; 19: 1783–94. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Urbanek K, Cesselli D, Rota M, et al Stem cell niches in the adult mouse heart. Proc Natl Acad Sci USA. 2006; 103: 9226–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Leri A, Rota M, Hosoda T, et al Cardiac stem cell niches. Stem Cell Res. 2014; 13: 631–46. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Bei Y, Wang F, Yang C, et al Telocytes in regenerative medicine. J Cell Mol Med. 2015; 19: 1441–54. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Zhao B, Chen S, Liu J, et al Cardiac telocytes were decreased during myocardial infarction and their therapeutic effects for ischaemic heart in rat. J Cell Mol Med. 2013; 17: 123–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Zhao B, Liao Z, Chen S, et al Intramyocardial transplantation of cardiac telocytes decreases myocardial infarction and improves post‐infarcted cardiac function in rats. J Cell Mol Med. 2014; 18: 780–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Bani D, Nistri S. New insights into the morphogenic role of stromal cells and their relevance for regenerative medicine. Lessons from the heart. J Cell Mol Med. 2014; 18: 363–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Popescu LM, Faussone‐Pellegrini MS. TELOCYTES ‐ a case of serendipity: the winding way from Interstitial Cells of Cajal (ICC), via Interstitial Cajal‐Like Cells (ICLC) to TELOCYTES. J Cell Mol Med. 2010; 14: 729–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Cretoiu SM, Popescu LM. Telocytes revisited. Biomol Concepts. 2014; 5: 353–69. [DOI] [PubMed] [Google Scholar]
- 32. Yang Y, Sun W, Wu SM, et al Telocytes in human heart valves. J Cell Mol Med. 2014; 18: 759–65. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Cretoiu D, Hummel E, Zimmermann H, et al Human cardiac telocytes: 3D imaging by FIB‐SEM tomography. J Cell Mol Med. 2014; 18: 2157–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Niculite CM, Regalia TM, Gherghiceanu M, et al Dynamics of telopodes (telocyte prolongations) in cell culture depends on extracellular matrix protein. Mol Cell Biochem. 2015; 398: 157–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Gherghiceanu M, Popescu LM. Cardiomyocyte precursors and telocytes in epicardial stem cell niche: electron microscope images. J Cell Mol Med. 2010; 14: 871–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Gherghiceanu M, Popescu LM. Cardiac telocytes ‐ their junctions and functional implications. Cell Tissue Res. 2012; 348: 265–79. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Mandache E, Popescu LM, Gherghiceanu M. Myocardial interstitial Cajal‐like cells (ICLC) and their nanostructural relationships with intercalated discs: shed vesicles as intermediates. J Cell Mol Med. 2007; 11: 1175–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Fertig ET, Gherghiceanu M, Popescu LM. Extracellular vesicles release by cardiac telocytes: electron microscopy and electron tomography. J Cell Mol Med. 2014; 18: 1938–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Cismasiu VB, Popescu LM. Telocytes transfer extracellular vesicles loaded with microRNAs to stem cells. J Cell Mol Med. 2015; 19: 351–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Popescu LM, Gherghiceanu M, Manole CG, et al Cardiac renewing: interstitial Cajal‐like cells nurse cardiomyocyte progenitors in epicardial stem cell niches. J Cell Mol Med. 2009; 13: 866–86. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Popescu LM, Curici A, Wang E, et al Telocytes and putative stem cells in ageing human heart. J Cell Mol Med. 2015; 19: 31–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Beltrami AP, Barlucchi L, Torella D, et al Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003; 114: 763–76. [DOI] [PubMed] [Google Scholar]
- 43. Dawn B, Stein AB, Urbanek K, et al Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci USA. 2005; 102: 3766–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Wong RCB, Pera MF, Pébay A. Role of gap junctions in embryonic and somatic stem cells. Stem Cell Rev. 2008; 4: 283–92. [DOI] [PubMed] [Google Scholar]
- 45. Camelliti P, Green CR, LeGrice I, et al Fibroblast network in rabbit sinoatrial node: structural and functional identification of homogeneous and heterogeneous cell coupling. Circ Res. 2004; 94: 828–35. [DOI] [PubMed] [Google Scholar]
- 46. Marthiens V, Kazanis I, Moss L, et al Adhesion molecules in the stem cell niche–more than just staying in shape? J Cell Sci. 2010; 123: 1613–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Harris TJC, Tepass U. Adherens junctions: from molecules to morphogenesis. Nat Rev Mol Cell Biol. 2010; 11: 502–14. [DOI] [PubMed] [Google Scholar]
- 48. Popescu LM, Gherghiceanu M, Cretoiu D, et al The connective connection: interstitial cells of Cajal (ICC) and ICC‐like cells establish synapses with immunoreactive cells. Electron microscope study in situ . J Cell Mol Med. 2005; 9: 714–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Gérard A, Beemiller P, Friedman RS, et al Evolving immune circuits are generated by flexible, motile, and sequential immunological synapses. Immunol Rev. 2013; 251: 80–96. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Krummel MF, Cahalan MD. The immunological synapse: a dynamic platform for local signaling. J Clin Immunol. 2010; 30: 364–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Gherghiceanu M, Popescu LM. Heterocellular communication in the heart: electron tomography of telocyte‐myocyte junctions. J Cell Mol Med. 2011; 15: 1005–11. [DOI] [PMC free article] [PubMed] [Google Scholar]